GL1X · GenesisL1 explorer

MolNFT v1 · #137076 · protein

Crystal structure of human MYT1 kinase domain in complex with MK1775

5VD0 · Membrane-associated tyrosine- and threonine-specific CDC2…: “Crystal structure of human MYT1 kinase domain in complex with MK1775”. X-ray diffraction, 1 ligand (8X7), 2 pockets (best druggability 0.70). MolNFT v1 #137076 on…

PDB
5VD0
Type
protein
Length
293 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Membrane-associated tyrosine- and threonine-specific CDC2- inhibitory kinase
EC
2.7.11.1
UniProt
Q99640
Ligands
8X7
Pockets
2 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 38% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMembrane-associated tyrosine- and threonine-specific CDC2- inhibitory kinase (EC 2.7.11.1)protein29338% helix, 18% strandQ99640

Ligands and binding sites

  • 8X7 · 1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one · ligand · chains A
  • PEG · Di(hydroxyethyl)ether · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
15910.700.79628X7
2600.310.7615empty

Compared structures

  • 5VD0 · Crystal structure of human MYT1 kinase domain in complex with MK1775 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q99640 · AlphaFold monomer V2.0 prediction for membrane-associated tyrosine- and… · a predicted model of the same protein · chain A against A, TM-score 0.97

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.